Bevacizumab (PBS), CAS 216974-75-3

Product Description: Bevacizumab, a humanized IgG1 monoclonal antibody, specifically binds to all VEGF-A isoforms with high affinity[1][2].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Di Mauro C, et al. Hedgehog signalling pathway orchestrates angiogenesis in triple-negative breast cancers. Br J Cancer. 2017 May 23;116(11):1425-1435./[2]Tan H, et al. 99mTc-labeled bevacizumab for detecting atherosclerotic plaque linked to plaque neovascularization and monitoring antiangiogenic effects of treatment in ApoE-/-mice. Sci Rep. 2017 Jun 14;7(1):3504.

CAS Number: 216974-75-3

Molecular Weight: N/A

Compound Purity: 98.94

Research Area: Cancer

Solubility: H2O

Target: VEGFR

• Artikelnummer: MEXHY-P9906A-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P9906A-5
• Green Labware: Nein
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK